Halotestin 100x5mg (UP)

Pure Strength & Aggression

Halotestin (Fluoxymesterone) is widely considered the most potent oral androgen in existence. It is not a mass builder; it is a pure strength and hardening agent. Powerlifters and strongmen use it for explosive power without weight gain. Bodybuilders use it in the final weeks pre-contest to achieve a "granite-hard," super-dry look.

Known for increasing aggression and drive, making it the ultimate pre-workout booster for record-breaking lifts.

Key Benefits:

• Extreme Strength: Unmatched strength gains rapidly.
• Muscle Hardening: removing subcutaneous water for a defined, grainy look.
• No Estrogen: Zero water retention or gynecomastia risk.
• Aggression: Increases drive and intensity in the gym.

Dosage:

• Standard: 10mg - 20mg per day.
• Advanced: Up to 40mg (short duration only).
• Duration: Maximum 3-4 weeks due to liver toxicity.

1. Description — Clinical summary

Halotestin (fluoxymesterone) 5 mg tablets is an oral androgenic-anabolic steroid. Fluoxymesterone is a synthetic derivative of testosterone with a 9α-fluoro-11β-hydroxy modification that dramatically increases its androgenic potency while maintaining relatively lower anabolic activity. It was historically approved for medical use in hypogonadism and certain breast cancers, though its clinical use has largely been discontinued.

Key points:

• Active compound: fluoxymesterone, oral tablets.
• Dosage form: 100 tablets per pack, 5 mg per tablet.
• Fluoxymesterone is one of the most potent oral androgens available, with an androgenic rating approximately 19 times that of testosterone.
• 17α-alkylated structure confers oral bioavailability but significantly increases hepatotoxicity.
• Short half-life of 6-8 hours necessitates multiple daily doses.

2. How does fluoxymesterone work?

Mechanism of action — pharmacology summary:

• Androgen receptor agonist: Fluoxymesterone binds the androgen receptor with very high affinity. The 9α-fluoro and 11β-hydroxy modifications increase receptor binding and resistance to metabolic inactivation.
• Non-aromatizing: Does not convert to estrogen. No estrogenic side effects such as water retention or gynecomastia from the compound itself.
• Erythropoietic effects: Stimulates red blood cell production, historically used for treating anemia.
• Strength enhancement: Known for disproportionate increases in strength relative to body weight gain, likely through central nervous system stimulation and enhanced neuromuscular signaling.
• Metabolic: Suppresses the HPG axis. Adverse effects on lipid metabolism (decreased HDL, increased LDL).
• Hepatic metabolism: 17α-alkylated, processed primarily by the liver with significant hepatotoxic potential.

3. Dosage — usage guidelines

A. Historical medical dosing:

• Male hypogonadism: 5-20 mg daily in divided doses.
• Breast cancer (palliative): 10-40 mg daily in divided doses.
• Delayed puberty in males: 2.5-10 mg daily for 4-6 months.

B. Reported non-medical use patterns (informational only):

• Typical reported patterns: 10-40 mg daily, divided into 2-3 doses due to the short half-life.
• Cycle length: commonly limited to 2-6 weeks due to significant hepatotoxicity.
• Primarily used for strength enhancement rather than mass gain.
• Often used in the final weeks before competition for aggression and strength.

C. Clinical management:

• Liver function tests mandatory before and during use (minimum every 2 weeks).
• Discontinue immediately if ALT/AST exceeds 3x upper limit of normal or jaundice develops.

4. Side effects — common and rare adverse effects

A. Very common adverse effects:

• Hepatotoxicity: elevated liver enzymes, cholestatic jaundice. One of the most hepatotoxic oral steroids.
• Androgenic effects: severe acne, oily skin, accelerated male pattern baldness.
• HPG axis suppression: complete suppression of endogenous testosterone production.
• Behavioral: pronounced aggression, irritability, mood swings, insomnia.
• Cardiovascular: significant adverse lipid changes, elevated blood pressure.

B. Serious/rare effects:

• Peliosis hepatis (blood-filled hepatic cysts) — potentially fatal.
• Hepatocellular carcinoma with prolonged use.
• Cholestatic hepatitis progressing to liver failure.
• Polycythemia and thrombotic events.
• Priapism (prolonged, painful erection).
• Virilization in women (irreversible effects possible with minimal exposure).

C. Monitoring:

• Liver function tests every 1-2 weeks during use.
• CBC with hematocrit, lipid panel, blood pressure.
• Serum testosterone, LH, FSH post-cycle.
• Discontinue and seek medical attention if signs of liver dysfunction appear.

5. Storage

• Store at controlled room temperature: 20-25°C (68-77°F). Brief excursions permitted between 15-30°C.
• Protect from light and moisture: keep in original packaging.
• Keep container tightly closed when not in use.
• Do not use tablets that appear discolored, damaged, or past expiration date.
• Keep out of reach of children and unauthorized persons.
• Dispose of unused tablets per local pharmaceutical disposal regulations.